Deals

Deal Announcement: Reata Pharmaceuticals

Geschrieben von MME | Jun 2, 2023 12:21:20 PM

Reata Pharmaceuticals, Inc. (Nasdaq: RETA), is a global pharmaceutical company primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs. Pharmakon Advisors, LP, is a leading investor in non-dilutive debt for the life sciences industry and the investment manager of the BioPharma Credit funds.

MME team was led by Peter Kuhn (Legal Partner) and included Thomas Linder (Tax Partner), Jacqueline Brunner (Legal Associate) and Eric Sutter (Senior Tax Advisor).